Previous studies have demonstrated that several enhancers interact with the ERBB4 promoter, implying that the elimination of this area can have an impact on ERBB4 expression, thereby contributing to breast cancer (Figure 3). The gene discussed is ERBB4; the disease is breast carcinoma.